Skip to main content
. 2020 Jul 6;12(7):1803. doi: 10.3390/cancers12071803

Figure 1.

Figure 1

Characterization of the anti-16E7 and anti-16E6 scFvs reactivity against the respective recombinant oncoproteins by ELISA. Data represent the mean ± SD of samples in quadruplicate from a representative experiment of three with similar results. (A) the anti-16E7 scFv9 (9), scFv32 (32), scFv43M2 (43M2), scFv51 (51) and (B) the anti-16E6 scFvI7 (I7) are indicated. Anti-16E7 polyclonal Ab and anti-16E6 mAb were used as positive controls.